Skip to main content
Peptron, Inc. logo

Peptron, Inc. — Investor Relations & Filings

Ticker · 087010 ISIN · KR7087010005 KO Manufacturing
Filings indexed 226 across all filing types
Latest filing 2024-10-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 087010

About Peptron, Inc.

http://www.peptron.com/

Peptron, Inc. is a biotechnology company specializing in peptide engineering and the development of sustained-release (SR) medications. The company's core focus is its proprietary SmartDepot platform technology, which enables the long-acting formulation of peptide-based drugs to treat chronic and life-threatening disorders. A key area of development is in neurodegenerative diseases, with a notable pipeline candidate being a sustained-release formulation of exenatide, based on patents exclusively licensed from the NIH. Peptron operates its own GMP-compliant manufacturing facility to produce its SR formulations, supporting its progression from pre-clinical research to commercial-stage development.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2024.11)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Peptron. It details amendments to a previously filed securities registration statement, specifically regarding changes in the maximum shareholder's stake due to a block deal and updates to risk factors related to the capital increase. This is a formal regulatory filing submitted to the Financial Supervisory Service (FSS) in South Korea. According to the provided definitions, this falls under 'Regulatory Filings' (RNS) as it is a formal regulatory document that does not fit into the more specific categories like 10-K (Annual Report) or ER (Earnings Release).
2024-10-22 Korean
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a '정정신고서' (Amendment Report) for an '투자설명서' (Investment Prospectus) filed by Peptron. It details specific amendments to the company's risk factors, particularly regarding the major shareholder's block deal and its impact on shareholding percentages and management stability. This is a formal regulatory filing related to a capital increase (rights offering) and is not a standalone report publication announcement, but rather the primary regulatory document itself. In the context of the provided categories, this fits best as a Regulatory Filing (RNS) as it is a formal amendment to a securities registration statement.
2024-10-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the shareholding changes of a specific executive (Choi Ho Il) of Peptron. This type of filing is a standard regulatory disclosure for insider trading or changes in executive share ownership, which corresponds to the 'Director's Dealing' category.
2024-10-21 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Peptron, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It includes detailed information on the issuance price, allocation methods, and subscription schedules. This type of filing is a standard regulatory disclosure in the Korean market regarding capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2024-10-07 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It specifically details a correction (정정) to the issuance terms of equity securities (지분증권) for Peptron (주식회사 펩트론), specifically updating the 1st issuance price (1차 발행가액 확정). This type of regulatory filing, which details capital raising activities and updates to previously filed registration statements, falls under the 'Capital/Financing Update' category.
2024-10-07 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a 'Investment Prospectus' (투자설명서) for Peptron Co., Ltd. regarding a capital increase (rights offering). It details the issuance of new shares, subscription periods, payment dates, and extensive risk factors associated with the investment. This document is a formal regulatory filing required for public offerings of securities, which falls under the category of 'Share Issue/Capital Change' (SHA) as it pertains to the issuance of new shares and capital structure changes.
2024-10-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.